A new artificial intelligence tool developed by researchers at Mass General Brigham can estimate a cancer patient's biological age and predict their survival outcomes from a single photograph of their face. This innovative approach aims to provide a non-invasive method for assessing prognosis.
In parallel, recent findings presented at the ARDD conference suggest that GLP-1 drugs, known for their use in diabetes and weight management, may also indicate slowed biological aging. While not directly related to the AI cancer prediction, these developments highlight the growing intersection of advanced technology and biological understanding in healthcare research.
AI Facial Analysis Predicts Cancer Survival, Drug Trials Show Biological Aging Clues
5 stories · 3 sources
#melatonin #cognition #researchOther digests
- 2026-10-20 — AI Facial Analysis Predicts Cancer Survival, Drug Trials Show Biological Aging Clues
- 2026-10-19 — AI Tool Predicts Cancer Survival From Patient Selfies
- 2026-10-18 — Antibody Signatures May Predict Inflammatory Bowel Disease a Decade Before Symptoms
- 2026-10-17 — GLP-1 Drugs Show Potential to Slow Biological Aging, New Research Suggests
- 2026-10-16 — RFK Jr. Urges FDA to Ignore Unproven Peptide Drugs
- 2026-10-15 — Army's Widespread Low-T Screening Faces Medical Expert Criticism
- 2026-10-14 — New Research Explores Melatonin's Impact on Cognitive Function
- 2026-10-13 — Pope Undergoes Successful Lung Surgery for Early-Stage Growth
- 2026-10-12 — Scientists Discover Previously Unknown Ocular Waste Removal System
- 2026-10-11 — Startup Develops Blood-Purification Tech to Combat Pediatric Sepsis
- 2026-10-10 — Protein's Dominance Explored in Scientific Discourse
- 2026-10-09 — Danish Researchers Proceed with Controversial Hepatitis B Vaccine Trial in Guinea-Bissau
- 2026-10-08 — UK Mental Health Services Face System Failures Amid Soaring ADHD, Autism Demand
- 2026-10-07 — Pediatricians Reiterate Raw Milk Dangers Amidst Misinformation
- 2026-10-06 — Nobel Prize Honors Optogenetics; Comedian Discloses Cancer Battle
- 2026-10-05 — Optogenetics Nobel Prize Highlights Light's Role in Brain Control
- 2026-10-04 — Digital Menstrual Trackers Raise Concerns Over Data Privacy and Potential Harm
- 2026-10-03 — New Research Explores Melatonin's Impact on Cognitive Function
- 2026-10-02 — New Drug Tirzepatide Significantly Reduces Fat Mass While Preserving Muscle
- 2026-10-01 — Australian Scientists Uncover Causes of Recurrent Bacterial Vaginosis
- 2026-09-30 — New Brain Wave Patterns Offer Deeper Insight into Neural Activity
- 2026-09-29 — Ukrainian Academy of Sciences, Vital to Nation's Research, Hit by Drone Attack
- 2026-09-28 — Gene-Edited Bananas Developed to Combat Browning, Reduce Food Waste
- 2026-09-27 — UK GPs Overwhelmed, Lacking Time for In-Depth Patient Consultations
- 2026-09-26 — New Pesticide Research Links 485 Chemicals to Breast Cancer
- 2026-09-25 — New Brain Tumour Test Slashes Diagnosis Time from Weeks to Hours
- 2026-09-24 — NHS Faces Two-Year Wait for ADHD, Autism Diagnoses Amid Soaring Demand
- 2026-09-23 — Millions in England Unaware of High Blood Pressure, 'Silent Killer' Risk
- 2026-09-22 — New Non-Invasive Test Offers Hope for Womb Cancer Detection in Postmenopausal Women
- 2026-09-21 — Switzerland Captain Xhaka Faces Ban Over Forged COVID Vaccine Certificate